Vir Biotechnology, Inc.
VIR
20 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jan 2 9:29 PM | VICKI LEE SATO | Proposed Sale | 66,000 | $6.03 | $398.0K | — | View → |
| Nov 25, 2025 | Nov 26 2:00 AM | SVF Endurance (Cayman) Limited | Proposed Sale | 1,251,303 | $6.44 | $8.1M | — | View → |
| Nov 17, 2025 | Nov 17 8:20 PM | O'Byrne Jason | Proposed Sale | 6,799 | $5.56 | $37.8K | — | View → |
| Nov 5, 2025 | Nov 5 2:47 PM | de Verneuil Vanina | Proposed Sale | 2,385 | $5.16 | $12.3K | — | View → |
| Nov 3, 2025 | Nov 3 8:30 PM | de Verneuil Vanina | Proposed Sale | 1,365 | $5.86 | $8.0K | — | View → |
| Oct 21, 2025 | Oct 22 1:00 AM | SVF Endurance (Cayman) Limited | Proposed Sale | 834,202 | $6.27 | $5.2M | — | View → |
| Oct 3, 2025 | Oct 3 9:00 PM | SVF Endurance (Cayman) Limited | Proposed Sale | 1,668,404 | $5.71 | $9.5M | — | View → |
| Oct 1, 2025 | Oct 1 8:32 PM | VICKI LEE SATO | Proposed Sale | 66,000 | $5.71 | $376.9K | — | View → |
| Jul 17, 2025 | Jul 17 8:18 PM | MARK EISNER | Proposed Sale | 3,586 | $5.41 | $19.4K | — | View → |
| Jul 15, 2025 | Jul 16 12:11 AM | Mark Eisner | Proposed Sale | 6,796 | $5.47 | $37.2K | — | View → |
| Jul 1, 2025 | Jul 1 8:25 PM | VICKI LEE SATO | Proposed Sale | 66,000 | $5.04 | $332.6K | — | View → |
| Jun 11, 2025 | Jun 11 9:59 PM | GEORGE SCANGOS | Proposed Sale | 19,957 | $5.41 | $108.0K | — | View → |
| Jun 10, 2025 | Jun 10 9:04 PM | GEORGE SCANGOS | Proposed Sale | 50,000 | $5.48 | $273.9K | — | View → |
| Jun 9, 2025 | Jun 9 9:55 PM | GEORGE SCANGOS | Proposed Sale | 50,000 | $5.41 | $270.6K | — | View → |
| Jun 2, 2025 | Jun 2 8:29 PM | JANET ANN NAPOLITANO | Proposed Sale | 3,200 | $4.94 | $15.8K | — | View → |
| Apr 3, 2025 | Apr 3 11:50 PM | Marianne De Backer | Proposed Sale | 79,712 | $5.95 | $474.2K | — | View → |
| Feb 26, 2025 | Feb 26 9:23 PM | VANINA DE VERNEUIL | Proposed Sale | 7,373 | $9.10 | $67.1K | — | View → |
| Feb 24, 2025 | Feb 25 1:57 AM | George Scangos | Proposed Sale | 10,056 | $9.45 | $95.1K | — | View → |
| Feb 24, 2025 | Feb 25 1:57 AM | Brent Sabatini | Proposed Sale | 1,562 | $9.45 | $14.8K | — | View → |
| Feb 24, 2025 | Feb 25 1:56 AM | Ann Hanly | Proposed Sale | 14,168 | $9.45 | $133.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Feb 26 9:56 PM | Vicki L SatoDirector | Option Exercise | 42,377 | $1.49 | 0(D) | View → |
| Feb 22, 2026 | Feb 25 12:13 AM | Brent SabatiniSVP, Chief Accounting Officer | Grant/Award | 50,000 | $7.56 | 50,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:12 AM | Jason O'ByrneEVP & Chief Financial Officer | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:11 AM | Mark EisnerEVP and Chief Medical Officer | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:10 AM | Verneuil Vanina deEVP, General Counsel, Corp Sec | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:09 AM | Backer Marianne DeDirector, Chief Executive Officer | Grant/Award | 570,000 | $7.56 | 570,000(D) | View → |